date:Aug 13, 2014
Ingredients segment was more than offset by organic sales growth of 13.3% in the smaller
Biochemicals market segment.
H1 2014 net sales was on par compared to H1 2013 at 371.0 million with organic growth of
2.0%, mainly driven by volume growth. Net sales were negatively impacted by exchange rate effects of -16.2 million (-4.4%), due to a weaker Japanese yen, Brazilian real and US dollar versus the Euro.
Q2 2014 compared to Q2 2013:
Major capital expenditure projects in 2014 are the pre